» Articles » PMID: 1908441

Functional Characterization of Tumor-infiltrating Lymphocytes, Lymph-node Lymphocytes and Peripheral-blood Lymphocytes from Patients with Breast Cancer

Overview
Journal Int J Cancer
Specialty Oncology
Date 1991 Aug 19
PMID 1908441
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mononuclear cell infiltration is frequently seen within human solid tumors. Effector cells within the tumor site usually fail to exhibit cytotoxic or natural killer activity when freshly isolated; however, they develop potent and sometimes specific cytotoxicity after expansion in IL2. Thus, local tumor environment may influence lymphocyte function. In our study, we disaggregated human breast-cancer and lymph-node tissue to obtain lymphocyte-enriched cell fractions. Besides phenotypic analysis, functional characterization with regard to proliferation and cytokine production of tumor-infiltrating lymphocytes (TIL), peripheral-blood lymphocytes (PBL) and lymph-node lymphocytes (LNL) was the aim of our study. TIL showed an enrichment of CD8+ cells with a corresponding decrease in CD4+ cells in comparison with PBL and LNL. In response to PHA, TIL showed decreased 3H-thymidine uptake, but TIL were significantly stimulated by rhIL2. TIL produced low levels of IL2, TNF and IFN gamma upon mitogen/phorbol ester stimulation, while PBL produce high levels of TNF and IFN gamma but low levels of IL2. Under the same experimental conditions, LNL produce high levels of TNF and IL2 but low levels of IFN gamma. Mitogen-mediated TNF secretion was increased after addition of autologous tumor cells in TIL and LNL, whereas IFN gamma secretion tended to be suppressed. Our results indicate different patterns of activities of TIL, LNL and PBL from breast-cancer patients.

Citing Articles

Identification of Functional Immune Biomarkers in Breast Cancer Patients.

Derakhshandeh R, Zhu Y, Li J, Hester D, Younis R, Koka R Int J Mol Sci. 2024; 25(22).

PMID: 39596374 PMC: 11595306. DOI: 10.3390/ijms252212309.


Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast.

Jamiyan T, Kuroda H, Yamaguchi R, Nakazato Y, Noda S, Onozaki M Breast Cancer. 2020; 27(5):880-892.

PMID: 32222891 PMC: 7438376. DOI: 10.1007/s12282-020-01084-1.


Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.

Battaglia A, Ferrandina G, Buzzonetti A, Malinconico P, Legge F, Salutari V Immunology. 2003; 110(3):304-12.

PMID: 14632657 PMC: 1783055. DOI: 10.1046/j.1365-2567.2003.01742.x.


Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.

Boldrini L, Calcinai A, Samaritani E, Pistolesi F, Mussi A, Lucchi M Br J Cancer. 2000; 83(4):480-6.

PMID: 10945495 PMC: 2374649. DOI: 10.1054/bjoc.2000.1345.


Immunotherapeutic approaches for the treatment of breast cancer.

Knutson K, Schiffman K, Rinn K, Disis M J Mammary Gland Biol Neoplasia. 2000; 4(4):353-65.

PMID: 10705919 DOI: 10.1023/a:1018714300217.